|
Diabetes, Vol 48, Issue 10 2052-2058, Copyright © 1999 by American Diabetes Association
Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo
E Bonnardel-Phu, JL Wautier, AM Schmidt, C Avila and E Vicaut
Department of Biophysics, F. Widal Hospital, Paris, France.
Advanced glycation end products (AGEs) are nonenzymatic glycosylated
adducts of proteins that accumulate in vascular tissue during diabetes and
aging. The aim of this work was to study the role of AGEs and of the
oxidative mechanisms in diabetes-induced changes in vascular permeability.
Intravital videomicroscopy was used to study albumin microvascular leakage
in cremaster muscle. The extravasation of a fluorescent macromolecular
tracer (fluorescein isothiocyanate-albumin) was measured for 1 h and, after
computer-aided image analysis, was expressed as variations of normalized
gray levels (arbitrary units). Extravasation of the macromolecular tracer
was much higher in diabetic rats than in control rats (slope of
extravasation versus time increased by >100%, P < 10(-4)). This
increase was significantly inhibited when we blocked AGEs binding to their
endothelial receptor by intravenous bolus of soluble recombinant receptor
to AGEs (rR-RAGE) (slope of extravasation versus time decreased by 19, 30,
and 40%, for 0.5, 2.5, and 5.15 mg/kg rR-RAGE, respectively) or by a 6
mg/kg intravenous bolus of antibody against RAGE (slope decreased by 53%).
Systemic injection of probucol (an antioxidant) also significantly
inhibited the increase in the extravasation of the macromolecular tracer
occurring in experimental diabetes (slope decreased by 51%, P < 10(-4)).
These results strongly suggest that in experimental diabetes the
interaction of circulating AGEs and endothelial RAGE mediates albumin
micro-vascular leakage, possibly via AGE-RAGE-dependent enhanced oxidant
stress.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Scalia, Y. Gong, B. Berzins, L. J. Zhao, and K. Sharma
Hyperglycemia Is a Major Determinant of Albumin Permeability in Diabetic Microcirculation: The Role of {micro}-Calpain
Diabetes,
July 1, 2007;
56(7):
1842 - 1849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Jensen, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and B. G. Nordestgaard
Increased Transvascular Lipoprotein Transport in Diabetes: Association with Albuminuria and Systolic Hypertension
J. Clin. Endocrinol. Metab.,
August 1, 2005;
90(8):
4441 - 4445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kankova, A. Stejskalova, M. Hertlova, and V. Znojil
Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus
Nephrol. Dial. Transplant.,
June 1, 2005;
20(6):
1093 - 1102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Stalker, Y. Gong, and R. Scalia
The Calcium-Dependent Protease Calpain Causes Endothelial Dysfunction in Type 2 Diabetes
Diabetes,
April 1, 2005;
54(4):
1132 - 1140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Wautier and A. M. Schmidt
Protein Glycation: A Firm Link to Endothelial Cell Dysfunction
Circ. Res.,
August 6, 2004;
95(3):
233 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al.
Activation of Tubular Epithelial Cells in Diabetic Nephropathy
Diabetes,
December 1, 2002;
51(12):
3532 - 3544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and J. S. Jensen
Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2002;
22(7):
1168 - 1174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Kent, V. M. Soukup, and R. H. Fabian
Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse
Stroke,
October 1, 2001;
32(10):
2318 - 2327.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|